The MAQI2 is an ongoing, multicenter, regional, collaborative registry of anticoagulation care, which seeks to improve the safety, quality of care and outcomes of patients requiring anticoagulation.

Welcome!

The Michigan Anticoagulation Quality Improvement Initiative (MAQI2) is a multicenter collaborative of anticoagulation clinics across the state of Michigan. MAQI2 seeks to improve the safety, quality of care and outcomes of patients requiring anticoagulation.

De-identified data from patients receiving anticoagulant therapy from six participating outpatient clinics (UMHS, Henry Ford Medical Center, Beaumont Hospital in Royal Oak, Spectrum Health in Grand Rapids, Huron Valley Sinai in Commerce, and Memorial Healthcare in Owosso) is entered into a data registry at the MAQI2 Coordinating Center located within the Michigan Cardiovascular Outcomes Research and Reporting Program (MCORRP) at the University of Michigan. Data collected includes: demographics, co-morbidities, lab values, and information on warfarin management. Outcomes such as bleeding events, ED visits and hospitalizations are also entered into the database.

Several quality metrics are used to compare performance between sites. Participating sites meet on a quarterly basis to review quality metrics, share Best Practices, and learn about the most recent anticoagulation management guidelines and research. Quality improvement initiatives are conducted to address poor performance at specific sites or across the entire collaborative.

MAQI2 Sites

Although Blue Cross Blue Shield of Michigan and MAQI2 work collaboratively, the opinions, beliefs and viewpoints expressed by the author do not necessarily reflect the opinions, beliefs and viewpoints of BCBSM or any of its employees.

Support for MAQI2 is provided by Blue Cross and Blue Shield of Michigan and Blue Care Network as part of the BCBSM Value Partnerships program. To learn more about Value Partnerships, www.valuepartnerships.com